Antibiotic resistance is a major public health issue throughout the world. The prospect that at some point, in the not too distant future, we may no longer be able to treat common infectious diseases, is one that we should all be concerned about.
Last year in Europe, more than 25,000 people died of bacterial infections resistant to antibiotics, and bacterial mutations resistant to current drugs continue to evolve.
Recently, it was reported that bacteria with the transmissible genetic element, New Delhi metallo-beta-lactamase 1 (NDM-1) had spread from India to the United Kingdom. What’s scary is this strain is resistant to most known beta-lactam antibiotics.
Which makes the discovery that biodegradable nanoparticles can break down the cell membranes of bacteria an important discovery. You can read more on Biotech Strategy Blog on how nanotechnology may help develop new anti-microbial therapies